Table 3: Univariate analysis of overall survival for C-HCC and NC-HCC patients.

Variables

Univariate analysis

C-HCC

NC-HCC

P value

HR

95%Cl

P value

HR

95% Cl

Age years: <65 vs. >65

0.121

0.815

0.628-1.056

0.915

0.945

0.506-1.840

Gender: male vs. female

0.27

0.821

0.99-1.045

0.883

0.951

0.484-1.867

BMI

0.22

1.017

0.806-1.431

0.047

0.929

0.863-0.999

Diabetes: Yes vs. No

0.138

0.813

0.619-1.069

0.377

0.725

0.373-1.408

Surveillance : Yes vs. No

<0.001

2.321

1.760-3.061

0.548

0.779

0.344-1.763

Etiology

0.543

1.021

.955-1.091

0.443

1.052

0.925-1.197

Extrahepatic metastasis: Yes vs. No

<0.001

0.256

0.173-0.377

0.247

0.631

0.289-1.375

Portal vein invasion: Yes vs. No

<0.001

0.153

0.107-.219

0.213

0.549

.214-1.410

BCLC stage

<0.001

2.289

2.010-2.607

0.028

1.655

1.057-2.591

Treatment            

<0.001

1.602

1.463-1.756

<0.001

1.348

1.143-1.589

C-HCC: Cirrhotic Hepatocellular Carcinoma Group; NC-HCC: Non-Cirrhotic Hepatocellular Carcinoma Group, BMI: Body Mass Index (cm /kg2); BCLC: Barcelona Clinic Liver Cancer; 95% Cl: Confidence Interval.